JP2005517654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517654A5 JP2005517654A5 JP2003552289A JP2003552289A JP2005517654A5 JP 2005517654 A5 JP2005517654 A5 JP 2005517654A5 JP 2003552289 A JP2003552289 A JP 2003552289A JP 2003552289 A JP2003552289 A JP 2003552289A JP 2005517654 A5 JP2005517654 A5 JP 2005517654A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- aryl
- nitrogen
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34217701P | 2001-12-17 | 2001-12-17 | |
| PCT/US2002/040015 WO2003051356A1 (en) | 2001-12-17 | 2002-12-13 | Method for treating circadian rhythm disruptions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005517654A JP2005517654A (ja) | 2005-06-16 |
| JP2005517654A5 true JP2005517654A5 (enExample) | 2007-05-17 |
Family
ID=23340700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003552289A Pending JP2005517654A (ja) | 2001-12-17 | 2002-12-13 | 日周期リズム障害の治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050107411A1 (enExample) |
| EP (1) | EP1463499A1 (enExample) |
| JP (1) | JP2005517654A (enExample) |
| AU (1) | AU2002351381B2 (enExample) |
| CA (1) | CA2469790A1 (enExample) |
| WO (1) | WO2003051356A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8396565B2 (en) | 2003-09-15 | 2013-03-12 | Medtronic, Inc. | Automatic therapy adjustments |
| MXPA06003393A (es) * | 2003-09-26 | 2006-06-08 | Pfizer Prod Inc | Tratamiento de trastornos neurologicos relacionados con alteraciones del sueno de movimientos oculares rapidos (rem) con antagonistas de receptor npy y5. |
| JP2007506728A (ja) * | 2003-09-26 | 2007-03-22 | ファイザー・プロダクツ・インク | 概日リズム障害を治療するためのｎｐｙｙ５受容体アンタゴニストの使用 |
| US7366572B2 (en) | 2004-03-16 | 2008-04-29 | Medtronic, Inc. | Controlling therapy based on sleep quality |
| WO2005089646A1 (en) | 2004-03-16 | 2005-09-29 | Medtronic, Inc. | Sensitivity analysis for selecting therapy parameter sets |
| US7491181B2 (en) * | 2004-03-16 | 2009-02-17 | Medtronic, Inc. | Collecting activity and sleep quality information via a medical device |
| US8725244B2 (en) | 2004-03-16 | 2014-05-13 | Medtronic, Inc. | Determination of sleep quality for neurological disorders |
| US7717848B2 (en) | 2004-03-16 | 2010-05-18 | Medtronic, Inc. | Collecting sleep quality information via a medical device |
| US7395113B2 (en) | 2004-03-16 | 2008-07-01 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
| US7330760B2 (en) | 2004-03-16 | 2008-02-12 | Medtronic, Inc. | Collecting posture information to evaluate therapy |
| US7313440B2 (en) | 2004-04-14 | 2007-12-25 | Medtronic, Inc. | Collecting posture and activity information to evaluate therapy |
| JP4993900B2 (ja) * | 2005-11-28 | 2012-08-08 | 国立大学法人 東京医科歯科大学 | 記憶障害抑制剤 |
| US7957809B2 (en) | 2005-12-02 | 2011-06-07 | Medtronic, Inc. | Closed-loop therapy adjustment |
| US8744587B2 (en) | 2006-03-24 | 2014-06-03 | Medtronic, Inc. | Collecting gait information for evaluation and control of therapy |
| US8688225B2 (en) | 2008-07-11 | 2014-04-01 | Medtronic, Inc. | Posture state detection using selectable system control parameters |
| US9440084B2 (en) | 2008-07-11 | 2016-09-13 | Medtronic, Inc. | Programming posture responsive therapy |
| US9050471B2 (en) | 2008-07-11 | 2015-06-09 | Medtronic, Inc. | Posture state display on medical device user interface |
| US8504150B2 (en) | 2008-07-11 | 2013-08-06 | Medtronic, Inc. | Associating therapy adjustments with posture states using a stability timer |
| US8644945B2 (en) | 2008-07-11 | 2014-02-04 | Medtronic, Inc. | Patient interaction with posture-responsive therapy |
| US8437861B2 (en) | 2008-07-11 | 2013-05-07 | Medtronic, Inc. | Posture state redefinition based on posture data and therapy adjustments |
| US8282580B2 (en) | 2008-07-11 | 2012-10-09 | Medtronic, Inc. | Data rejection for posture state analysis |
| US9327070B2 (en) | 2009-04-30 | 2016-05-03 | Medtronic, Inc. | Medical device therapy based on posture and timing |
| US8231555B2 (en) | 2009-04-30 | 2012-07-31 | Medtronic, Inc. | Therapy system including multiple posture sensors |
| US9956418B2 (en) | 2010-01-08 | 2018-05-01 | Medtronic, Inc. | Graphical manipulation of posture zones for posture-responsive therapy |
| US8579834B2 (en) | 2010-01-08 | 2013-11-12 | Medtronic, Inc. | Display of detected patient posture state |
| US8758274B2 (en) | 2010-01-08 | 2014-06-24 | Medtronic, Inc. | Automated adjustment of posture state definitions for a medical device |
| US9357949B2 (en) | 2010-01-08 | 2016-06-07 | Medtronic, Inc. | User interface that displays medical therapy and posture data |
| US9566441B2 (en) | 2010-04-30 | 2017-02-14 | Medtronic, Inc. | Detecting posture sensor signal shift or drift in medical devices |
| US9556242B2 (en) * | 2011-01-24 | 2017-01-31 | Anygen Co., Ltd. | Method for regulating circadian rhythms |
| US9907959B2 (en) | 2012-04-12 | 2018-03-06 | Medtronic, Inc. | Velocity detection for posture-responsive therapy |
| US9737719B2 (en) | 2012-04-26 | 2017-08-22 | Medtronic, Inc. | Adjustment of therapy based on acceleration |
| CN105492010B (zh) * | 2013-08-19 | 2020-01-03 | 豪夫迈·罗氏有限公司 | 用于治疗相移睡眠障碍的V1a拮抗剂 |
| US11596795B2 (en) | 2017-07-31 | 2023-03-07 | Medtronic, Inc. | Therapeutic electrical stimulation therapy for patient gait freeze |
| CZ310035B6 (cs) * | 2019-12-09 | 2024-05-29 | Univerzita PalackĂ©ho v Olomouci | N-(furan-2-ylmethyl)-7H-purin-6-amin pro modulaci cirkadiánních rytmů |
| US12453859B2 (en) | 2021-02-24 | 2025-10-28 | Medtronic, Inc. | Posture state definition calibration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242941A (en) * | 1990-12-04 | 1993-09-07 | State Of Oregon | Methods of treating circadian rhythm disorders |
| JP4228398B2 (ja) * | 1997-04-23 | 2009-02-25 | 萬有製薬株式会社 | 神経ペプチドｙ受容体拮抗剤 |
| AU8474298A (en) * | 1997-07-31 | 1999-02-22 | Bristol-Myers Squibb Company | A method for modulation of circadian rhythmicity |
| DE19824175A1 (de) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino-azol-Verbindungen |
| EP1129089B1 (en) * | 1998-11-10 | 2005-12-28 | Merck & Co., Inc. | Spiro-indolines as y5 receptor antagonists |
| AU2935200A (en) * | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
| TWI279402B (en) * | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
-
2002
- 2002-12-13 US US10/497,558 patent/US20050107411A1/en not_active Abandoned
- 2002-12-13 AU AU2002351381A patent/AU2002351381B2/en not_active Ceased
- 2002-12-13 WO PCT/US2002/040015 patent/WO2003051356A1/en not_active Ceased
- 2002-12-13 CA CA002469790A patent/CA2469790A1/en not_active Abandoned
- 2002-12-13 JP JP2003552289A patent/JP2005517654A/ja active Pending
- 2002-12-13 EP EP02787039A patent/EP1463499A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1248683C (zh) | 二肽基肽酶iv抑制剂在制备治疗2型糖尿病的药物中的用途 | |
| AU723954B2 (en) | Non-allosteric gabaA agonists for treating sleep disorders | |
| RU2008117432A (ru) | Способы применения 3-(4-амино-1-оксо-1,3-дигидроизоиндол-2-ил)пиперидин-2,6-диона для лечения определенных типов лейкоза | |
| WO2003079979A3 (en) | Method for treating congestive heart failure | |
| CA2501651A1 (en) | Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability | |
| JP2006513184A5 (enExample) | ||
| WO2007075554A3 (en) | Combination of igfr inhibitor and anti-cancer agent | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| IL208184A0 (en) | Glp-1, and methods for treating diabetes | |
| RU2004131680A (ru) | Производные бензофурана | |
| WO2004045593A3 (en) | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| BG108072A (en) | The use of epothilone derivatives for the treatment of refractory tumors | |
| RU2005101411A (ru) | Антагонисты метаботропного глутаматного рецептора 5 (mglur5) и способ для профилактики и лечения гастро-эзофагеальной рефлюксной болезни (варианты) | |
| RU2005136383A (ru) | Применение дипиридамола или мопидамола для лечения и предупреждения тромбоэмболических заболеваний и нарушений, вызываемыхизбыточным образованием и/или повышенным уровнем экспрессии тромбиновых рецепторов | |
| CN1511036A (zh) | 包含信号转导抑制剂和埃坡霉素衍生物的联合形式 | |
| WO2002089805A3 (en) | Use of regularly scheduled high dose intravenous methotrexate therapy | |
| JP2023524789A5 (enExample) | ||
| WO2004010946A3 (en) | Therapeutic treatment for the metabolic syndrome and type 2 diabetes | |
| JP2006514681A5 (enExample) | ||
| JP2021514380A5 (ja) | 筋障害及び骨障害を処置するための化合物及び組成物 | |
| RU2003127718A (ru) | Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости | |
| JP2005513036A5 (enExample) | ||
| WO2007079195A3 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
| JPH08501069A (ja) | 強心剤と一酸化窒素合成抑制剤の併用による病的低血圧の治療 |